Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
povidone-iodine + isopropyl alcohol + bupivacaine hydrochloride + dexamethasone sodium
- Development stage
- Unknown
- Lead developer
- Enovachem
- Modality
- Small Molecules
- Administration
- Topical, Parenteral
01
Overview
This appears to be a **multi-ingredient peri-procedural combination** consisting of the topical antiseptics povidone-iodine and isopropyl alcohol together with the local anesthetic bupivacaine hydrochloride and the corticosteroid dexamethasone sodium. Based on the provided context, the intended use would be to combine skin antisepsis with local anesthesia and anti-inflammatory effects around a procedure. However, the supplied evidence does **not** identify a specific branded or sponsor-defined pharmaceutical product containing exactly these four ingredients together, and the excerpt provided specifically supports only bupivacaine hydrochloride as an established anesthetic component rather than the full four-component combination as a verified marketed or clinical-stage asset.
- Other names
- povidone-iodine + isopropyl alcohol + bupivacaine hydrochloride + dexamethasone sodium
02
Targets
GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on povidone-iodine + isopropyl alcohol + bupivacaine hydrochloride + dexamethasone sodium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on povidone-iodine + isopropyl alcohol + bupivacaine hydrochloride + dexamethasone sodium.